文献速递临床试验与 GCP流行病学与生物统计

亚洲和非洲六月龄以下婴儿生长迟缓的营养管理:多中心随机试验研究方案(BRANCH,母乳喂养咨询与生长管理)

Nutritional management of growth faltering in infants aged under six months in Asia and Africa: study protocol for a multicentre randomised trial (BRANCH, BReAstfeediNg Counselling and management of growtH).
PubMed 文献 · Trials · 2025-11-06

该多中心、平行组、个体随机、非盲对照试验在亚洲和非洲七国纳入11000名胎龄至少28周的婴儿,于7至14日龄随机分组,比较强化母乳喂养咨询与支持(IBFCS)联合营养性母乳补充(NMS)与单用IBFCS对6月龄时死亡率、患病率和生长的影响,主要结局为6月龄时无消瘦生存。

要点

  • 研究在孟加拉国、印度、巴基斯坦、埃塞俄比亚、尼日利亚、坦桑尼亚和乌干达七国开展。
  • 纳入胎龄至少28周的婴儿11000名,于7至14日龄个体随机分组。
  • 主要结局为6月龄时无消瘦生存(体重别身长标准差评分不低于-2 SD)。

核心结论

  • 该大型随机试验将提供证据说明NMS对强化母乳喂养咨询与支持及医学问题处理后仍无应答的生长迟缓婴儿是否具有作用。

研究设计与样本

  • 多中心、平行组、个体随机、非盲对照试验,在亚洲三国(孟加拉国、印度、巴基斯坦)和非洲四国(埃塞俄比亚、尼日利亚、坦桑尼亚、乌干达)实施。
  • 纳入11000名胎龄至少28周的婴儿,于7至14日龄个体随机分组。
  • 每位婴儿的母亲接受培训过的同伴咨询员提供的母乳喂养支持,研究人员每1至2周入户随访收集生长和结局数据。

关键数值与推荐

  • 主要结局为6月龄时无消瘦生存,即存活且体重别身长标准差评分不低于-2 SD。
  • 符合生长问题研究标准(体重增长缓慢、生长关注或生长迟缓)的婴儿由研究临床医生评估、治疗医学问题,其母亲接受IBFCS。
  • 干预组中生长迟缓的婴儿额外接受营养性母乳补充(NMS),即按Codex Alimentarius标准计算以满足追赶生长需求的足月婴儿配方奶处方量。
  • 对照组仅接受IBFCS。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of growth faltering in early infancy may improve short and long term child health outcomes. The overall aim of this trial is to determine, in infants who meet study criteria for growth faltering, the effect of intensive breastfeeding counselling and support (IBFCS) plus nutritional milk supplementation (NMS) compared with IBFCS alone, on mortality, morbidity and growth at 6 completed months in low resource settings in South Asia and Sub-Saharan Africa. The primary outcome of the trial is wasting free survival (alive without wasting (weight for length standard deviation score < - 2 standard deviations (SD))) at 6 completed months of age. METHODS: This is a multi-centre, parallel-group, individually-randomized, non-blinded, controlled trial implemented in seven countries: three in Asia (Bangladesh, India and Pakistan) and four in Africa (Ethiopia, Nigeria, Tanzania and Uganda). Eleven thousand (11,000) infants with a gestational age of at least 28 weeks are enrolled and individually randomised between 7 and 14 days of age. The mother of each infant receives breastfeeding support from trained peer counsellors. Research workers follow up each infant 1-2 weekly at the infant's home to collect growth and outcome data. If infants meet study criteria for growth problems (slow weight gain, growth concern or growth faltering) they are reviewed by study clinicians, their medical problems are treated, and their mothers receive IBFCS. Infants with growth faltering in the intervention arm also receive nutritional milk supplementation (NMS) (prescribed quantities of term infant formula that meets Codex Alimentarius standards calculated to fulfill the needs for catch up growth). The comparison group receives IBFCS alone. Weekly growth monitoring continues and final outcome data (mortality, wasting) are measured in all infants at 6 completed months. DISCUSSION: This large randomised trial will provide evidence about the role of NMS, if any, in infants with growth faltering who do not respond to IBFCS and treatment of medical problems in low resource settings. TRIAL REGISTRATION: Australian and New Zealand Clinical Trial Registry (ANZCTR) CTRN12624000704594. Registered on June 4 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nutritional management of growth faltering in infants aged under six months in Asia and Africa: study protocol for a multicentre randomised trial (BRANCH, BReAstfeediNg Counselling and management of growtH). Trials. 2025. PMID: 41199298. doi:10.1186/s13063-025-09034-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。